Sito in Italia dove è possibile acquistare la consegna acquisto Viagra a buon mercato e di alta qualità in ogni parte del mondo.

Xerox.it

Material Safety Data Sheet
______________________________________________________________________________________________ SDS # : A-0009
Dry Imager -Black
Issuing Date 1983-01-25
Revision Date 2011-07-27
Version 1
1. PRODUCT AND COMPANY IDENTIFICATION
Trade Name:
2020, 2300, 2350, 2600, 2700, 3100, 3100 LDC, 3103,3107, 3109, 3300, 3400, 3450, 3700, 8040, 8040 SeriesEP, 4045, XP10, XP10E, XP12, XP12E, XP24 Part No. 006R00099, 006R00134, 006R00223, 006R00224, 006R00400, 006R00401, 006R00410,
006R00402, 006R00403, 006R90123, 006R00047, 006R00049, 006R00033, 006R00067, 006R00068,
006R00072, 006R00074, 006R00091, 006R00100, 006R00101, 006R00189, 006R00233, 006R00508
Pure substance/preparation
Identified uses
Manufacturer
Emergency telephone
Safety Information (800)828-6571Health Emergency (585)422-2177Chemical Emergency only (Chemtrec) (800)424-9300or (703)527-3887 (collect outside the US or Canada) Emergency Overview
The product contains no substances which, in the form utilized and at their given concentrations, are considered to Appearance
Physical state
Potential Health Effects
Principle Routes of Exposure

Acute toxicity
Inhalation
Ingestion
Chronic effects
Chronic toxicity

No known effects under normal use conditions. Repeated or prolonged inhalation maycause irritation of the respiratory tract as can occur with the inhalation of any non- toxicdust. Minimum respiratory or eye irritation may occur as with exposure to large amounts ofany non-toxic dust.
Main symptoms
Overexposure may cause:mildrespiratory irritation Aggravated Medical Conditions None under normal use conditions
SDS # : A-0009
Dry Imager -Black
______________________________________________________________________________________________ Environmental hazard
See Section 12 for additional Ecological Information Risk Phrases
3. COMPOSITION/INFORMATION ON INGREDIENTS Chemical Name
General advice
When symptoms persist or in all cases of doubt seek medical advice. Show this materialsafety data sheet to the doctor in attendance.
Eye contact
Immediately flush with plenty of water. After initial flushing, remove any contact lenses andcontinue flushing for at least 15 minutes Skin contact
Inhalation
Ingestion
Rinse mouth with water and afterwards drink plenty of water or milk Notes to physician
Protection of first-aiders
No special protective equipment required.
Flammable properties
Not flammable. Will not readily ignite.
Flash point
Suitable extinguishing media
Use water spray or fog; do not use straight streams, Foam Unsuitable extinguishing media
Do not use a solid water stream as it may scatter and spread fire Hazardous combustion products
Hazardous decomposition products due to incompletecombustion, Carbon oxides, Nitrogen oxides (NOx) Explosion Data
Sensitivity to Mechanical Impact
Sensitivity to Static Discharge
Fine dust dispersed in air, in sufficient concentrations, and in thepresence of an ignition source is a potential dust explosionhazard.
Specific hazards arising from the chemical
Fine dust dispersed in air, in sufficient concentrations, and in the presence of an ignition source is a potential dust explosion
hazard.
SDS # : A-0009
Dry Imager -Black
______________________________________________________________________________________________ Protective Equipment and Precautions for Firefighters
In the event of fire and/or explosion do not breathe fumes. Wear fire/flame resistant/retardant clothing. Use self-contained
pressure-demand breathing apparatus if needed to prevent exposure to smoke or airborne toxins.
NFPA 704
Consumer use

Health Hazard
Flammability
Stability
Special hazard
Bulk Packaging
Health Hazard
Flammability
Stability
Special hazard
Personal Precautions
Environmental Precautions
Refer to protective measures listed in Sections 7 and 8.
Methods for containment
Methods for cleaning up
Prevent dust cloud. Sweep up or vacuum up spillage and collect in suitable container fordisposal. Use non-sparking tools and equipment.
Other Information
See Section 12 for additional information Advice on safe handling
Handle in accordance with good industrial hygiene and safety practiceAvoid dust accumulation in enclosed spacePrevent dust cloud Technical measures/Storage
Keep container tightly closed in a dry and well-ventilated place conditions
Hygiene measures
Industrial User
Do not eat, drink or smoke when using this productWash hands before eating, drinking, chewing gum, using tobacco, or using toiletWash hands before breaks and at the end of workdayProvide regular cleaning of equipment, work area and clothing Exposure guidelines
Product information

ACGIH TLV TWA
ACGIH TLV TWA
OSHA PEL TWA
OSHA PEL TWA
Xerox Exposure Limit
Xerox Exposure Limit
SDS # : A-0009
Dry Imager -Black
______________________________________________________________________________________________ Other Information
The results obtained from a Xerox sponsored Chronic Toner Inhalation Study demonstrated no lung changes in rats for the lowest
(1mg/m3 ) exposure level (the level most relevant to potential human exposure). A very slight degree of fibrosis was noted in 25%
of animals at the middle (4mg/m3 )exposure level, while a slight degree of fibrosis was noted in all the animals at the highest
(16mg/m3 ) exposure level. These findings are attributed to "lung overloading", a generic response to excessive amounts of any
dust retained in the lungs for a prolonged period. This study was conducted using a special test toner to comply with an EPA
testing protocol.
Biological standards
This product, as supplied, does not contain any hazardous materials with biological limits established by the region specific
regulatory bodies
Occupational Exposure Controls
Engineering measures
Industrial use
Avoid dust formationEnsure all equipment is electrically grounded before beginning transfer operationsProvide appropriate exhaust ventilation at places where dust is formed Personal Protective Equipment
Consumer use
These recommendations apply to the product as supplied Respiratory protection
No special protective equipment required.
Eye/Face protection
No special protective equipment required.
Skin and body protection
No special protective equipment required.
Hand protection
Industrial use
In case of insufficient ventilation:Wear protective eyewear (goggles)Effective dust mask Appearance
Odor threshold
Physical state
Flash point
point/range
Softening point
Autoignition
temperature
Flammability Limits in Air
Explosive properties
Fine dust dispersed in air, in sufficient concentrations, and in the presence of an ignitionsource is a potential dust explosion hazard Vapor pressure
Vapor density
SDS # : A-0009
Dry Imager -Black
______________________________________________________________________________________________ Water solubility
Viscosity
Partition coefficient
Evaporation rate
Melting point/range
Freezing point
Specific gravity
Reactivity
No dangerous reaction known under conditions of normal use Stability
Incompatible products
Conditions to Avoid
Prevent dust cloud, Fine dust dispersed in air, in sufficient concentrations, and in thepresence of an ignition source is a potential dust explosion hazard Hazardous Decomposition Products None under normal use
Hazardous polymerization
Hazardous reactions
Acute toxicity
Product information

Irritation
LD50 Oral:
LD50 Dermal:
LC50 Inhalation:
Chronic toxicity
Product information

Chronic effects
No known effects under normal use conditions. Repeated or prolonged inhalation maycause irritation of the respiratory tract as can occur with the inhalation of any non- toxicdust. Minimum respiratory or eye irritation may occur as with exposure to large amounts ofany non-toxic dust.
Carcinogenicity
See "Other Information" in this section.
Chemical Name
Other toxic effects
Product information

Sensitization
Mutagenic effects
Target organ effects
Other adverse effects
Aspiration Hazard
SDS # : A-0009
Dry Imager -Black
______________________________________________________________________________________________ Other information
The IARC (International Agency for Research on Cancer) has listed carbon black as "possibly carcinogenic to humans". The classification is based
on studies evaluating pure, "free" carbon black. In contrast, toner is a formulation composed of specially prepared polymer and a small amount of
carbon black (or other pigment). In the process of making toner, the small amount of carbon black becomes encapsulated within a matrix. Xerox
has performed extensive testing of toner, including a chronic bioassay (test for potential carcinogenicity). Exposure to toner did not produce
evidence of cancer in exposed animals. The results were submitted to regulatory agencies and published extensively.
Ecotoxicity
The environmental impact of this product has not been fully investigated. However, this preparation is not expected to present
significant adverse environmental effects.
Waste Disposal Methods
This material, as supplied, is not a hazardous waste according to Federal regulations (40CFR 261). This material could become a hazardous waste if it is mixed with or otherwisecomes in contact with a hazardous waste, if chemical additions are made to this material, orif the material is processed or otherwise altered. Consult 40 CFR 261 to determine whetherthe altered material is a hazardous waste. Consult the appropriate state, regional, or localregulations for additional requirements Contaminated packaging
Dispose of in accordance with local regulations.
This material is not subject to regulation as a hazardous material for shipping.
International Inventories
TSCA

U.S. Federal Regulations
SARA 313
Section 313 of Title III of the Superfund Amendments and Reauthorization Act of 1986 (SARA). This product does not contain any
chemicals which are subject to the reporting requirements of the Act and Title 40 of the Code of Federal Regulations, Part 372.
SARA 311/312 Hazard Categories
Acute Health Hazard
Chronic Health Hazard
Fire Hazard
Sudden Release of Pressure Hazard
Reactive Hazard
Clean Water Act
This product does not contain any substances regulated as pollutants pursuant to the Clean Water Act (40 CFR 122.21 and 40
CFR 122.42).
Clean Air Act, Section 112 Hazardous Air Pollutants (HAPs) (see 40 CFR 61)
This product does not contain any substances regulated as hazardous air pollutants (HAPS) under Section 112 of the Clean Air
Act Amendments of 1990.
SDS # : A-0009
Dry Imager -Black
______________________________________________________________________________________________ CERCLA
This material, as supplied, does not contain any substances regulated as hazardous substances under the Comprehensive
Environmental Response Compensation and Liability Act (CERCLA) (40 CFR 302) or the Superfund Amendments and
Reauthorization Act (SARA) (40 CFR 355). There may be specific reporting requirements at the local, regional, or state level
pertaining to releases of this material.
TSCA
TSCA 12b does not apply to this product.
U.S. State Regulations
California Proposition 65
This product does not contain any Proposition 65 chemicals.
Chemical Name
California Prop. 65
U.S. State Right-to-Know Regulations
Canada
This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations (CPR) and
the MSDS contains all the information required by the CPR.
WHMIS Hazard Class
Not subject to WHMIS classification
Issuing Date
Revision Date
Revision Note
Disclaimer
The information provided on this MSDS is correct to the best of our knowledge, information and belief at the date of its publication. The
information given is designed only as a guide for safe handling, use, processing, storage, transportation, disposal and release and is not
to be considered as a warranty or quality specification. The information relates only to the specific material designated and may not be
valid for such material used in combination with any other material or in any process, unless specified in the text

Source: http://www.xerox.it/download/ehs/msds/A-0009.en-us.pdf

Untitled

I. INTRODUCTION The named End-Payor plaintiffs seek class certification of a class comprised of individual consumers, third-party payors (“TPPs”), union plan sponsors, and insurance companies that purchased or provided reimbursements for Nexium in those states that permit such an action. See Corrected Consol. Am. Class Action Compl. & Demand Jury Trial (“End-Payors’ Compl.”)

Abstract

CYPROHEPTADINE, PIZOTIFEN AND AMITRYPTILINE AS PROPHYLACTIC THERAPY IN CYCLIC VOMITING SYNDROME S. Martinazzi, M. Fuoti, M. Brusati, A. Ravelli University Department of Pediatrics, Children’s Hospital, Spedali Civili – Brescia (Italy) BACKGROUND AND AIM. Cyclic vomiting syndrome (CVS) is a functional gastrointestinal disorder of unknown origin that causes severe recurrent attack

Copyright © 2010-2014 Medicament Inoculation Pdf